Holen Sie sich die Stockscreener-App
125.97
2.60%
-3.36
Handel nachbörslich:
128.31
2.34
+1.86%
Schlusskurs vom Vortag:
$129.33
Offen:
$128.05
24-Stunden-Volumen:
335.43K
Relative Volume:
0.39
Marktkapitalisierung:
$3.62B
Einnahmen:
$267.23M
Nettoeinkommen (Verlust:
$-83.50M
KGV:
-40.50
EPS:
-3.11
Netto-Cashflow:
$-59.99M
1W Leistung:
-1.72%
1M Leistung:
+19.82%
6M Leistung:
+28.53%
1J Leistung:
+273.47%
1-Tages-Spanne:
$125.49
$129.97
1-Wochen-Bereich:
$125.00
$136.00
52-Wochen-Spanne:
$32.11
$136.00
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Vergleichen Sie WGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
125.97 | 3.72B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
482.41 | 184.14B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
194.33 | 142.23B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
655.60 | 52.23B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
126.25 | 36.32B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
189.64 | 31.91B | 15.70B | 1.24B | 2.01B | 6.91 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
GeneDx at Morgan Stanley Conference: Rare Disease Focus By Investing.com - Investing.com Canada
GeneDx Holdings Corp. Equity Warrant Moves Into Overbought Range Analysts CautiousMarket Performance Report & Fast Entry Momentum Alerts - beatles.ru
Pattern Scan Adds GeneDx Holdings Corp. Equity Warrant to WatchlistM&A Rumor & Weekly Setup with High ROI Potential - beatles.ru
GeneDx at Morgan Stanley Conference: Rare Disease Focus - Investing.com
Momentum Traders Eye GeneDx Holdings Corp. Equity Warrant for Quick BounceJuly 2025 Intraday Action & Verified Short-Term Plans - beatles.ru
Trapped Investors in GeneDx Holdings Corp. Equity Warrant Await Breakout SignalEarnings Risk Summary & Community Trade Idea Sharing - beatles.ru
GeneDx (WGS): Valuation in Focus Following Securities Investigation Triggered by Fraud Allegations - Yahoo Finance
Earnings visualization tools for GeneDx Holdings Corp.July 2025 Earnings & Safe Capital Growth Tips - Newser
GeneDx Holdings Corp. stock chart pattern explained2025 Trading Recap & Stock Portfolio Risk Control - Newser
Using economic indicators to assess GeneDx Holdings Corp. Equity Warrant potential2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
GeneDx Holdings Corp. (NASDAQ:WGS) Looks Just Right With A 25% Price Jump - 富途牛牛
Sentiment analysis tools applied to GeneDx Holdings Corp.Trade Analysis Summary & Free High Return Stock Watch Alerts - Newser
How to build a dashboard for GeneDx Holdings Corp. Equity Warrant stockJuly 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Can GeneDx Holdings Corp. disrupt its industryJuly 2025 Price Swings & Real-Time Volume Analysis - خودرو بانک
How to manage a losing position in GeneDx Holdings Corp.Market Trend Summary & Entry Point Confirmation Alerts - Newser
Statistical indicators supporting GeneDx Holdings Corp. Equity Warrant’s strengthCPI Data & Accurate Technical Buy Alerts - Newser
Can GeneDx Holdings Corp. Equity Warrant outperform in the next rallyEarnings Miss & Technical Confirmation Trade Alerts - خودرو بانک
Price momentum metrics for GeneDx Holdings Corp. Equity Warrant explained2025 Sector Review & High Yield Stock Recommendations - Newser
Will GeneDx Holdings Corp. outperform the marketEntry Point & Smart Investment Allocation Insights - Newser
WGS Investor News: If You Have Suffered Losses in GeneDx - GlobeNewswire
How sentiment analysis helps forecast GeneDx Holdings Corp. Equity WarrantForecast Cut & Advanced Swing Trade Entry Plans - Newser
Is GeneDx Holdings Corp. a candidate for recovery play2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Will GeneDx Holdings Corp. Equity Warrant stock recover after recent dropTrade Entry Summary & Weekly Breakout Stock Alerts - Newser
GeneDx Holdings Corp. Equity Warrant stock momentum explainedQuarterly Performance Summary & Technical Buy Zone Confirmation - Newser
Relative strength of GeneDx Holdings Corp. Equity Warrant in sector analysis2025 Trading Volume Trends & Safe Entry Trade Reports - Newser
News impact scoring models applied to GeneDx Holdings Corp.Portfolio Value Summary & Stepwise Swing Trade Plans - Newser
Pittsburgh Post-Gazette - FinancialContent
GeneDx at Wells Fargo Conference: Diagnostic Ambitions - Investing.com India
Is GeneDx Holdings Corp. a turnaround storyWeekly Gains Report & Fast Gaining Stock Strategy Reports - خودرو بانک
What is the next catalyst for GeneDx Holdings Corp.July 2025 Intraday Action & Stepwise Trade Execution Plans - خودرو بانک
Is GeneDx Holdings Corp. Equity Warrant stock a smart retirement pick2025 Biggest Moves & Long-Term Safe Investment Ideas - خودرو بانک
RSI Reset May Fuel Rebound in GeneDx Holdings Corp.Buy Signal & Technical Entry and Exit Alerts - beatles.ru
Can GeneDx Holdings Corp. reach resistance levels soonJuly 2025 Sentiment & Precise Swing Trade Alerts - خودرو بانک
Advanced analytics toolkit walkthrough for GeneDx Holdings Corp. Equity WarrantOptions Play & High Win Rate Trade Alerts - Newser
Published on: 2025-09-04 06:51:59 - Newser
GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Bragar Eagel & Squire investigates GeneDx Holdings Corp. for potential fraud. - AInvest
About Us - FinancialContent
GeneDx Holdings Corp. Equity Warrant stock daily chart insightsTrade Risk Report & Fast Entry High Yield Stock Tips - Newser
Aug Big Picture: What is the next catalyst for GeneDx Holdings Corp.Volume Spike & Verified Entry Point Signals - خودرو بانک
GeneDx raises 2025 revenue guidance to $415M and exome/genome revenue growth to 52% while accelerating NICU and pediatric market expansion - MSN
Geopolitics Watch: Can GeneDx Holdings Corp. Equity Warrant outperform in the next rallyJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - خودرو بانک
GeneDx Holdings Corp.’s volatility index tracking explainedJuly 2025 Trends & AI Based Buy/Sell Signal Reports - Newser
What MACD and RSI say about GeneDx Holdings Corp. Equity Warrant2025 Short Interest & Verified Technical Signals - Newser
Price momentum metrics for GeneDx Holdings Corp. explainedEarnings Growth Summary & Weekly Chart Analysis and Guides - Newser
Real time pattern detection on GeneDx Holdings Corp. stockBull Run & Risk Managed Trade Strategies - Newser
Does GeneDx Holdings Corp. Equity Warrant fit your quant trading modelGDP Growth & AI Forecast Swing Trade Picks - Newser
GeneDx CFO Feeley sells $47,556 in shares - Investing.com
GeneDx CFO Feeley sells $47,556 in shares By Investing.com - Investing.com UK
Aug Breakouts: Can GeneDx Holdings Corp. stock double in the next year2025 Trade Ideas & Community Verified Trade Alerts - خودرو بانک
What institutional flow reveals about GeneDx Holdings Corp2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Sep 02 '25 |
Sale |
125.81 |
378 |
47,556 |
4,096 |
| Ryan Jason | Director |
Aug 27 '25 |
Sale |
127.30 |
38,072 |
4,846,708 |
103,284 |
| Ryan Jason | Director |
Aug 27 '25 |
Sale |
129.65 |
1,150 |
149,093 |
11,904 |
2.86%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):